Which GLP-1 Is Best for Weight Loss?

Let's be honest: the GLP-1 world has a naming problem. Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus — it sounds like a law firm, not a medicine cabinet. Half of these are the same drug wearing different outfits, which nobody tells you upfront.

This guide cuts through the brand-name fog. We'll compare what each one actually is, what the trials showed, how the side effects stack up, and — the part most articles skip — what happens after the weight comes off. Because the drug is only half the story.

GLP-1 weight loss comparison: the numbers

Here's the head-to-head from the major clinical trials. Every figure below is an average from clinical trials — real people land above and below these numbers, and your doctor is the only one who can say what to expect for you.

*Ozempic's trials studied diabetes doses; the ~15% figure reflects semaglutide at weight-loss doses (Wegovy). Rybelsus shows meaningful but smaller average weight loss than the injectables in trials.

Ozempic

The one that started it all — the household name. Ozempic is semaglutide, taken as a weekly injection, and it's FDA-approved for type 2 diabetes (not weight loss, though doctors do prescribe it off-label for weight management). It has the longest real-world track record of the bunch, which means the most safety data and the most insurance plans that recognize it.

One thing to know: if you're comparing Ozempic vs Mounjaro for weight loss, the trial averages favor tirzepatide — but Ozempic's familiarity means many doctors reach for it first, especially if you also have blood sugar concerns.

Wegovy

Wegovy is the same active ingredient as Ozempic (semaglutide) — just at a higher dose, with FDA approval specifically for chronic weight management. Think of it as Ozempic's weight-loss sibling: same family, different job description.

In the STEP clinical trials, Wegovy averaged around 15% body-weight loss — the result that made headlines and launched a thousand before-and-after photos. If your doctor mentions semaglutide for weight loss, this is usually the version they mean.

Mounjaro

Mounjaro is tirzepatide, a weekly injection FDA-approved for type 2 diabetes. It's the newer kid on the block, and the one generating the most buzz — because in the SURMOUNT trials it posted the highest average weight loss of any GLP-1 so far, around 20–21% at the top dose.

Tirzepatide works a little differently: it mimics two gut hormones (GLP-1 and GIP) instead of one, which researchers believe explains the extra effect. Our full guide on what to eat on Mounjaro covers the food side if this is the one you're on or considering.

Zepbound

Zepbound is the same active ingredient as Mounjaro (tirzepatide) — the difference is the label. Zepbound carries FDA approval for chronic weight management (and later for sleep apnea), while Mounjaro's approval is for diabetes. Same medication, same trial results, different paperwork.

This is the Zepbound vs Wegovy matchup everyone asks about: tirzepatide's ~20% vs semaglutide's ~15% in trial averages. Again — averages, not promises, and your doctor weighs far more than the headline numbers.

Rybelsus

The odd one out — and for some people, the most interesting. Rybelsus is semaglutide in a daily pill, no injection required. The trade-off: average weight loss in trials was smaller than the injectables, and the pill comes with fussy rules (take on an empty stomach, with a sip of water, wait 30 minutes before eating).

Still, if needles are a hard no for you, it's a legitimate conversation to have with your doctor rather than skipping treatment entirely.

Side effects: how they compare

Here's the unglamorous truth: the side effects are pretty similar across all of them. Nausea is the headliner — especially in the first weeks and after dose increases — followed by vomiting, constipation or diarrhea, and the occasional food aversion that makes your former favorite meal sound disgusting. (The chicken breast betrayal is real. We've heard it a hundred times.)

No GLP-1 has clearly proven itself the "gentle" one. Individual tolerance varies more than the differences between drugs, and starting low + titrating slowly helps with every single one of them. What you eat matters enormously too — small, bland, protein-first meals beat large rich ones every time. Our Mounjaro nausea eating guide applies to all of them.

If side effects are persistent or severe on any of these medications, that's a call-your-doctor situation, not a tough-it-out one.

Which one should you ask your doctor about?

Only your doctor can answer this for real — but it helps to walk in knowing which questions matter for you:

The part nobody talks about: keeping the weight off

Here's what the comparison charts leave out: the drug gets the weight off, but your habits keep it off. Clinical trials show most people regain significant weight within a year of stopping — because appetite comes roaring back and the eating patterns never changed.

Two things matter more than which brand name is on your prescription:

• Protect your muscle. Rapid weight loss can strip lean muscle along with fat — and less muscle means a slower metabolism and faster regain. Our guide on preventing muscle loss on GLP-1 covers exactly how to fight this.
• Hit your protein target. Protein is the single biggest lever for keeping lost weight as fat, not muscle. Here's how much protein you need on GLP-1 — plus the free calculator.

Think of it this way: the medication is the tailwind. Protein and muscle are the engine. You want both.

Which GLP-1 is best for weight loss: questions, answered